Human Wild-Type α-Synuclein Drives Progressive Tau Pathology in a Disease-Relevant Mouse Model of Synucleinopathy
Sudipta Senapati(The University of Texas Medical Branch at Galveston), Rakez Kayed(The University of Texas Medical Branch at Galveston)
Cited by 0
Related Papers
Controlled drug delivery vehicles for cancer treatment and their performance
|Signal Transduction and Targeted Therapy|2018|2.1k
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
|Molecular Neurodegeneration|2011|614
RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction
|Nature Communications|2020|94